Search Result |
Top |
| Entry | Name | Description | Category | Pathway | Gene |
|---|---|---|---|---|---|
| H00002 |
T-cell acute lymphoblastic leukemia T-cell acute lymphocytic leukemia |
... survival, and differentiation during thymocyte development. In this context, constitutive activation of NOTCH1 signaling is the most prominent oncogenic pathway in T cell transformation. In addition, T-ALLs ... | Cancer |
NOTCH1 (mutation) [HSA:4851] [KO:K02599] TAL1 (overexpression) [HSA:6886] [KO:K09068] TAL2 [HSA:6887] [KO:K09068] LYL1 (expression) [HSA:4066] [KO:K15604] MLL-ENL (translocation) [HSA:4297] [KO:K09186] HOX11 (translocation) [HSA:3195] [KO:K09340] MYC (translocation) [HSA:4609] [KO:K04377] LMO2 (translocation) [HSA:4005] [KO:K15612] HOX11L2 (translocation) [HSA:30012] [KO:K15607] PICALM-MLLT10 (translocation) [HSA:8028] [KO:K23588] |
|
| H00031 | Breast cancer | ... pathways, and stimulate cell growth, survival and differentiation. In patients suffering from TNBC, the deregulation of various signalling pathways (Notch, Wnt/beta-catenin, and EGFR) have been confirmed. | Cancer | hsa05224 Breast cancer |
BRCA1 (germline mutation, hypermethylation) [HSA:672] [KO:K10605] BRCA2 [HSA:675] [KO:K08775] BARD1 [HSA:580] [KO:K10683] BRIP1 [HSA:83990] [KO:K15362] PALB2 [HSA:79728] [KO:K10897] RAD51 [HSA:5888] [KO:K04482] RAD54L [HSA:8438] [KO:K10875] XRCC3 [HSA:7517] [KO:K10880] ERBB2/HER2 (overexpression) [HSA:2064] [KO:K05083] ESR1/ER1 [HSA:2099] [KO:K08550] PGR [HSA:5241] [KO:K08556] GATA3 [HSA:2625] [KO:K17895] PIK3CA [HSA:5290] [KO:K00922] TP53 [HSA:7157] [KO:K04451] PPM1D [HSA:8493] [KO:K10147] RB1CC1 [HSA:9821] [KO:K17589] HMMR [HSA:3161] [KO:K06267] NQO2 [HSA:4835] [KO:K08071] SLC22A18 [HSA:5002] [KO:K08214] PTEN [HSA:5728] [KO:K01110] EGFR (overexpression) [HSA:1956] [KO:K04361] KIT (overexpression) [HSA:3815] [KO:K05091] NOTCH1 (overexpression) [HSA:4851] [KO:K02599] NOTCH4 (overexpression) [HSA:4855] [KO:K20996] FZD7 (overexpression) [HSA:8324] [KO:K02432] LRP6 (overexpression) [HSA:4040] [KO:K03068] FGFR1 (amplification) [HSA:2260] [KO:K04362] CCND1 (amplification) [HSA:595] [KO:K04503] |
| H00187 | Ornithine transcarbamylase deficiency | Ornithine transcarbamylase deficiency, the most common urea cycle defect, results in failure to thrive, hypotonia, seizures and mental retardation. | Inherited metabolic disorder | OTC [HSA:5009] [KO:K00611] | |
| H00517 | Spondylocostal dysostosis | ... characterized by vertebral defects along the entire spinal column with rib fusions and deletions. SCD arises from disturbed somite segmentation during embryonic development due to mutations in Notch pathway genes. | Congenital malformation |
(SCDO1) DLL3 [HSA:10683] [KO:K06051] (SCDO2) MESP2 [HSA:145873] [KO:K09076] (SCDO3) LNFG [HSA:3955] [KO:K05948] (SCDO4) HES7 [HSA:84667] [KO:K09087] (SCDO5) TBX6 [HSA:6911] [KO:K10180] (SCDO6) RIPPLY2 [HSA:134701] |
|
| H00536 | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) | ... chronic cerebrovascular disorder characterized by recurrent ischemic attacks and frequent migraines associated with diffuse white-matter abnormalities. CADASIL is caused by mutations in the NOTCH3 gene. | Congenital malformation | NOTCH3 [HSA:4854] [KO:K20995] | |
| H00551 | Alagille syndrome | ... including pulmonic stenosis/ peripheral pulmonary stenosis and tetralogy of Fallot. Affected individuals show typical facies and abnormal butterfly vertebrae as well. Mutations in the Notch pathway cause ALGS. | Congenital malformation |
(ALGS1) JAG1 [HSA:182] [KO:K06052] (ALGS2) NOTCH2 [HSA:4853] [KO:K20994] |
|
| H00554 |
Aortic valve disease Bicuspid aortic valve |
Aortic valve disease (AOVD), also known as bicuspid aortic valve, is the most common congenital heart defect with strong male predominance. It may arise in isolation or in association with other congenital ... | Congenital malformation |
(AOVD1) NOTCH1 [HSA:4851] [KO:K02599] (AOVD2) SMAD6 [HSA:4091] [KO:K04677] (AOVD3) ROBO4 [HSA:54538] [KO:K06784] |
|
| H00623 | Hajdu-Cheney syndrome | ... acro-osteolysis, osteoporotic changes of the spine/long bones of extremities, and insufficient ossification of the skull. Disturbed notch pathway that plays a role in bone formation leads to these anomalies. | Musculoskeletal disease | NOTCH2 [HSA:4853] [KO:K20994] | |
| H00686 | Manitoba oculotrichoanal syndrome | ... characterized by aberrant anterior hairline, upper-eyelid colobomas, hypertelorism, cryptophthalmos, a bifid or notched nose, and anal anomalies. MOTA syndrome is inherited in an autosomal recessive manner. | Congenital malformation | FREM1 [HSA:158326] [KO:K23380] | |
| H01272 | Hypoplastic left heart syndrome | ... mitral and aortic valves. There is now strong evidence implicating multiple genetic loci for HLHS. Potential mutations in at least 4 genes, GJA1, NKX2-5, NOTCH1, and HAND1, have been associated with HLHS. | Congenital malformation |
GJA1 [HSA:2697] [KO:K07372] NKX2-5 [HSA:1482] [KO:K09345] HAND1 [HSA:9421] [KO:K09071] |
|
| H01398 | Primary hyperammonemia (Urea cycle disorders) | Hyperammonemia is a metabolic condition characterized by elevated levels of ammonia in the blood, and may result in irreversible brain damage if not treated early and thoroughly. Hyperammonemia can be ... | Inherited metabolic disorder |
NAGS [HSA:162417] [KO:K11067] CPS1 [HSA:1373] [KO:K01948] OTC [HSA:5009] [KO:K00611] ASS1 [HSA:445] [KO:K01940] ASL [HSA:435] [KO:K01755] ARG1 [HSA:383] [KO:K01476] SLC25A15 [HSA:10166] [KO:K15101] SLC25A13 [HSA:10165] [KO:K15105] |
|
| H01413 | Adams-Oliver syndrome | ... and skull lesions, and transverse limb abnormalities. Mutations in ARHGAP31 (AOS1), RBPJ (AOS3) and NOTCH1 (AOS5) cause autosomal dominant AOS. Mutations in DOCK6 (AOS2) and EOGT (AOS4) result in autosomal ... | Congenital malformation |
(AOS1) ARHGAP31 [HSA:57514] [KO:K20646] (AOS2) DOCK6 [HSA:57572] [KO:K21852] (AOS3) RBPJ [HSA:3516] [KO:K06053] (AOS4) EOGT [HSA:285203] [KO:K18134] (AOS5) NOTCH1 [HSA:4851] [KO:K02599] (AOS6) DLL4 [HSA:54567] [KO:K06051] |
|
| H01508 | Salivary gland cancer | ... the MECT1-MAML2 fusion protein. This fusion transcript can activate transcription of targets in the Notch pathway. Epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) ... | Cancer |
CRTC1-MAML2 (translocation) [HSA:23373 84441] [KO:K15309 K06061] MYB-NF1B (translocation) [HSA:4602] [KO:K09420] ETV6-NTRK3 (translocation) [HSA:4916] [KO:K05101] EGFR (overexpression) [HSA:1956] [KO:K04361] HER2 (overexpression) [HSA:2064] [KO:K05083] CDKN2A (deletion) [HSA:1029] [KO:K06621] |
|
| H01577 | Essential tremor | Essential tremor (ET) is a neurological disorder that is considered to be one of the most common adult-onset movement disorders. ET is typically characterized by rhythmic, involuntary shaking of one or ... | Nervous system disease |
(ETM1) DRD3 [HSA:1814] [KO:K04146] (ETM4) FUS [HSA:2521] [KO:K13098] (ETM5) TENM4 [HSA:26011] [KO:K24473] (ETM6) NOTCH2NLC [HSA:100996717] [KO:K24466] |
|
| H01663 | Pustular psoriasis | ... form of psoriasis [DS:H01656] characterized by multiple tender sterile pustules with an underlying, blotchy, erythematous base. It has been classified into localized and generalized forms. Generalized pustular ... | Immune system disease; Skin disease | ||
| H01893 |
Lateral meningocele syndrome Lehman syndrome |
... abnormality, and aortic dilation, a high-pitched nasal voice, wormian bones, and osteolysis may be present. NOTCH3 gain of function mediated via loss of the PEST degradation domain is associated with LMS. | Congenital malformation | NOTCH3 [HSA:4854] [KO:K20995] | |
| H01910 | Infantile myofibromatosis | ... there have been several reports of autosomal dominant inheritance pattern. Mutations in the PDGFRB and NOTCH3 genes were recently identified in patients with IM. Treatment options vary widely. Solitary and ... | Neoplasm |
(IMF1) PDGFRB [HSA:5159] [KO:K05089] (IMF2) NOTCH3 [HSA:4854] [KO:K20995] |
|
| H02513 | Oculopharyngodistal myopathy | Oculopharyngodistal myopathy (OPDM) is an adult-onset inherited neuromuscular disorder characterized by progressive ptosis, external ophthalmoplegia, and weakness of the masseter, facial, pharyngeal, and ... | Musculoskeletal disease |
(OPDM1) LRP12 [HSA:29967] [KO:K20050] (OPDM2) GIPC1 [HSA:10755] [KO:K20056] (OPDM3) NOTCH2NLC [HSA:100996717] [KO:K24466] (OPDM4) RILPL1 [HSA:353116] [KO:K20173] |
| [ KEGG | DISEASE | DRUG | MEDICUS ] |